Camp4 Therapeutics director granted 28K options
Camp4 Therapeutics Corp director and 10% owner Amir Nashat received a grant of stock options for 28,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Camp4 Therapeutics Corp director and 10% owner Amir Nashat received a grant of stock options for 28,000 shares of common stock. The options have an exercise price of $4.34 per share and no cash was paid at grant. They vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of stockholders, as long as Nashat continues to provide service through that date. After this grant, he holds options for 28,000 shares, which expire on June 9, 2036.
Insider Trade Summary
Grant/Award: 28,000 shares
Grant/Award
1 txn
Insider
Nashat Amir
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.
Key Figures
Options granted: 28,000 options
Exercise price: $4.34 per share
Expiration date: June 9, 2036
+2 more
5 metrics
Options granted
28,000 options
Stock Option (Right to Buy) grant to Amir Nashat
Exercise price
$4.34 per share
Exercise price of Camp4 Therapeutics stock options
Expiration date
June 9, 2036
Option expiration for Nashat’s 28,000 options
Shares underlying options
28,000 shares
Common stock underlying the granted options
Total options after grant
28,000 options
Total derivative holdings following this transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "4.3400" per share as exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares underlying the option vest in their entirety on the earlier of the first anniversary..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders"
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Camp4 Therapeutics (CAMP) report for Amir Nashat?
Camp4 Therapeutics reported that director and 10% owner Amir Nashat received a grant of stock options for 28,000 shares of common stock, with an exercise price of $4.34 per share and no cash paid at grant, as compensation.
What are the key terms of Amir Nashat’s 28,000 Camp4 Therapeutics options?
The grant covers 28,000 options on Camp4 Therapeutics common stock at an exercise price of $4.34 per share. All options expire on June 9, 2036, giving a long window to exercise if vesting and service conditions are met.
When do Amir Nashat’s Camp4 Therapeutics stock options vest?
The options vest in full on the earlier of the first anniversary of the grant date or the date of Camp4 Therapeutics’ next annual meeting of stockholders, provided Nashat continues to serve the company through that vesting date.
How many Camp4 Therapeutics options does Amir Nashat hold after this grant?
Following the reported transaction, Amir Nashat holds options for 28,000 shares of Camp4 Therapeutics common stock. The filing shows this grant as his derivative position, with no additional remaining derivative holdings listed in the summary section.
What is the significance of the June 9, 2036 expiration for CAMP options granted to Nashat?
The options expire on June 9, 2036, giving roughly a decade-long exercise window after vesting. This long duration is typical for equity-based compensation and allows Nashat extended time to decide when to exercise, depending on service and company performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates